Aramark (ARMK) Stock Price & How to Invest

Aramark feeds and services places other people own. It holds multi-year contracts to run cafeterias for corporate campuses, dining and retail for colleges and K-12 districts, patient and staff food service inside hospitals, and concessions plus premium hospitality at stadiums, arenas, convention centers and national parks. Alongside the food is a facilities business covering custodial work, plant operations, energy management and grounds. The reporting structure splits into Food and Support Services United States (organized around Business & Industry, Education, Healthcare, Sports, Leisure & Corrections, and Facilities) and Food and Support Services International, which spans Europe, Latin America and Asia. In September 2023 the company completed the tax-free spin-off of its uniforms and workplace supplies segment as Vestis Corporation (NYSE: VSTS), distributing one Vestis share for every two Aramark shares held. That separation removed a capital-intensive route-based rental business and left Aramark as a pure-play food and facilities operator.

The investment picture is a services roll-forward rather than a product cycle. Growth comes from three levers stacked on top of each other: net new business (winning contracts from competitors or from clients still running food service in-house), base volume inside existing accounts, and price. Fiscal 2026 has run at the upper end of that framework: at its second-quarter report management guided to organic revenue growth at the high end of a ~7% to ~9% range, adjusted operating income growth of ~12% to ~17%, and adjusted EPS growth of ~20% to ~25%. The fiscal third quarter (ended July 3, 2026) brought revenue of about $5.06 billion, up roughly 9.3% year over year, and adjusted EPS of $0.52 against a $0.48 estimate, the second beat in a row. TTM revenue is now about $19.85 billion. The stock has rewarded the execution: as of October 16, 2026 it closed at $55.85, up about 53% year to date and 45% over the past year, within a 52-week range of $35.07 to $62.65. What makes the model durable is switching friction: replacing a food-service provider across an entire hospital system or university means retendering, transitioning thousands of frontline staff and rebuilding menus, so retention rates in this industry run high. What caps it is thin margins. Operating margins sit in the mid single digits, the cost base is overwhelmingly labor and food, and the balance sheet still carries meaningful leverage, so small swings in wage inflation or commodity costs move earnings more than they move revenue.

Food-service contracting is a low-margin, high-labor business, so wage inflation, staffing shortages and food-cost spikes compress profit faster than they show up in revenue, and pass-through pricing tends to lag by a quarter or more. Contract concentration matters in the other direction too: losing a large university system, hospital network or stadium account removes revenue immediately while the associated overhead unwinds slowly. Client budgets are not immune to macro pressure, since corporate campus dining volumes fall with office attendance and stadium per-capita spending falls with consumer discretionary income. The balance sheet still carries meaningful leverage relative to operating income, which makes refinancing costs and interest rates a live variable for equity holders. Labor relations are a recurring friction: in September 2026 the UNITE HERE Local 11 union urged an Arizona county sheriff's office to replace Aramark through its food and commissary RFP, the kind of public campaign that can put corrections contracts at risk. Finally, valuation leaves little slack: after a roughly 53% gain in 2026 the shares trade near 39 times trailing earnings and about 20 times forward estimates, so the stock is already priced for the guided earnings acceleration to land rather than slip.

16 analysts publish price targets on ARMK, averaging $68.53 against a $54.41 price as of November 2026, or +26.0%. The published targets run from $47.00 to $75.50, a moderate spread, and the ratings split 14 buy, 1 hold, 1 sell. Over the last six months there have been 12 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full ARMK forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Aramark. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Net new business and the outsourcing runway. A large share of institutional food service in the US and abroad is still self-operated, which means Aramark's addressable market includes clients who have never outsourced at all. The most optimistic published target, $75.50, assumes this works close to its best case.

The case against. Food-service contracting is a low-margin, high-labor business, so wage inflation, staffing shortages and food-cost spikes compress profit faster than they show up in revenue, and pass-through pricing tends to lag by a quarter or more. The most pessimistic target, $47.00, is roughly what ARMK is worth if this bites instead.

Read the full bull and bear case on ARMK, including what would have to change to break either one. Walnut is not an investment adviser.

Yes. Aramark (ARMK) has had one share split in the last 10 years:

• 1385:1000 on October 2, 2023, so every share held became 1.385 shares.

A split changes the share count and the price per share and leaves the value of a holding unchanged. Someone holding $1,000 of ARMK the day before the 1385:1000 split held $1,000 the day after, in more shares at a proportionally lower price. Historical prices from before the date are normally shown split-adjusted, which is why a long-run chart shows no cliff.

Splits matter mainly because they make older price figures confusing to compare by hand, and because a board choosing to split is usually signalling that the price has run up far enough to feel awkward for smaller buyers. Neither is a reason to buy or sell.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Aramark's investor relations page or your broker.

• Revenue (TTM): ~$19.85 billion
• Revenue growth (fiscal Q3 2026, year over year): ~9.3%
• Operating / net margin: ~4.4% / ~1.9%
• Net income (TTM): ~$383 million
• P/E (trailing / forward): ~39x / ~20x
• Market capitalization: ~$14.7 billion
• Dividend: $0.12 per share quarterly, yield ~0.9%

Aramark trades at about 39 times trailing earnings but only about 20 times forward estimates, a gap that reflects the expected jump in earnings (consensus fiscal 2026 EPS of about $2.28, up about 25%, and fiscal 2027 near $2.81). At roughly 0.74 times sales and 14 times EV/EBITDA, the multiple is carried by margin improvement on a low base, with debt of about $6.47 billion still large next to a $14.7 billion market cap. Fiscal fourth-quarter results are expected around late November 2026.

Other names that sit close to ARMK: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get ARMK exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so ARMK sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where ARMK fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Aramark is a contract-driven services compounder whose value depends on client retention and slow, steady margin gains, not on a breakthrough product. After a roughly 53% run in 2026, the shares trade near 20 times forward earnings, so the fiscal fourth-quarter report expected in late November has to confirm the guided earnings step-up.

Whether ARMK is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ARMK a buy or a sell?, and where the stock could go from here in the ARMK stock forecast.

For income investors, whether ARMK pays a dividend and how the payout looks is covered in does ARMK pay a dividend? And to weigh ARMK against a peer, read the full side-by-side comparisons: ARMK vs COMP and ARMK vs ABM.